Patent ID: 7375120

Claim:
A compound according to formula (I): wherein: R is selected from the group consisting of: C 2-6 alkyl (optionally substituted by alkoxy, halogen, or C 1-3 alkylsulfanyl); C 2-6 alkenyl (optionally substituted by alkoxy, halogen, or C 1-3 alkylsulfanyl); C 2-6 alkynyl (optionally substituted by alkoxy, halogen, or C 1-3 alkylsulfanyl); (CH 2 ) n —C 3-6 carbocycle (optionally substituted by alkoxy, halogen, or C 1-3 alkylsulfanyl); and (CH 2 ) n —R4, wherein R4 is selected from the group consisting of phenyl, furan, benzofuran, thiophene, benzothiophene, tetrahydrofuran, tetrahydropyran, dioxane, 1,4-benzodioxane and benzo[1,3]dioxole; R4 is optionally substituted by one or more substituents selected from Cl, Br, I, C 1-3 alkyl (optionally substituted by one to three F) and C 1-2 alkoxy (optionally substituted by one to three F); R1 represents hydrogen or C 1-4 alkyl; R2 represents C 1-6 alkyl, ArC 1-4 alkyl, wherein substitution is through the alkyl carbon, or Ar; Ar is selected from the group consisting of phenyl, naphthyl, furyl, pyridyl, thienyl, thiazolyl, isothiazolyl, pyrazolyl, triazolyl, tetrazolyl, imidazolyl, imidazolidinyl, benzofuranyl, indolyl, thiazolidinyl, isoxazolyl, oxadiazolyl, thiadiazolyl, morpholinyl, piperidinyl, piperazinyl, pyrrolyl, and pyrimidyl; all of which may be unsubstituted or substituted by one or more Z 1 or Z 2 groups; Z 1 and Z 2 are, independently, selected from the group consisting of hydrogen, C 1-4 alkyl, C 1-4 alkoxy, (CH 2 ) n CO 2 R1, C(O)NRR1, CN, (CH 2 ) n OH, NO 2 , halogen, NHR 2 , and NHC(O)R2; and n is an integer from 0 to 4; or a pharmaceutically acceptable salt thereof.